8 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $270M | $15M | 57.5% | 8.5% | $12M | $12M | $14M |
| 2024 | $224M | $11M | 59.4% | 8.0% | $1M | $4M | $18M |
| 2023 | $183M | $10M | 61.6% | 7.8% | $19M | $7M | $13M |
| 2022 | $139M | $6M | 61.0% | 5.9% | $5M | $0 | $17M |
| 2021 | $117M | $9M | 62.7% | 9.9% | $3M | $6M | $28M |
| 2020 | $131M | $32M | 61.0% | 20.4% | $22M | $8M | $31M |
| 2019 | $80M | $9M | 69.8% | 11.0% | $6M | $9M | $13M |
| 2018 | $64M | $10M | 74.1% | 15.6% | $16M | $0 | $10M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $75M | $3M | 56.8% | 5.7% | $1M | $9M | $10M |
| Dec '25 | $76M | $6M | 57.9% | 11.0% | $10M | $12M | $14M |
| Sep '25 | $72M | $4M | 57.5% | 7.8% | $11M | $21M | $11M |
| Jun '25 | $63M | $3M | 58.3% | 8.1% | $4M | $4M | $20M |
| Mar '25 | $59M | $3M | 56.3% | 6.5% | -$13M | $4M | $10M |
| Dec '24 | $61M | $4M | 59.5% | 10.6% | $3M | $4M | $18M |
| Sep '24 | $58M | $4M | 59.3% | 9.7% | $2M | $4M | $11M |
| Jun '24 | $55M | $1M | 59.8% | 6.6% | $1M | $9M | $9M |
| Mar '24 | $51M | $2M | 58.9% | 4.4% | -$5M | $7M | $7M |
| Dec '23 | $51M | $3M | 63.3% | 10.4% | $5M | $7M | $13M |
| Sep '23 | $49M | $3M | 61.9% | 8.5% | $6M | $10M | $10M |
| Jun '23 | $43M | $2M | 60.3% | 6.7% | $2M | $15M | $10M |
| Mar '23 | $40M | $2M | 60.7% | 4.9% | $6M | — | $24M |
| Dec '22 | $38M | $2M | 61.0% | 9.4% | $2M | $0 | $17M |
| Sep '22 | $36M | $1M | 60.5% | 4.1% | $2M | $4M | $21M |
| Jun '22 | $33M | $967000 | 61.2% | 3.0% | -$2M | $5M | $22M |
| Mar '22 | $32M | $2M | 61.2% | 7.0% | $3M | $5M | $29M |
| Dec '21 | $32M | $4M | 61.5% | 14.6% | $2M | $6M | $28M |
| Sep '21 | $29M | $2M | 62.8% | 10.0% | -$3M | $6M | $27M |
| Jun '21 | $27M | $2M | 64.3% | 9.7% | $933000 | $7M | $31M |
How the market has priced VMD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, VIEMED HEALTHCARE, INC.'s revenue has grown 15.5% per year, and net income declined 13.4% per year. These are computed facts, not advice.
As of FY2025, VIEMED HEALTHCARE, INC. reported $12M of total debt against $14M of cash.
In FY2025, gross margin was 57.5%, operating margin 8.5%, and net margin 5.7%.
As of Jun '26, VIEMED HEALTHCARE, INC. traded at a price-to-earnings ratio of about 29.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.